ATE504592T1 - Trehaloseverbindung und arzneimittel mit der verbindung - Google Patents

Trehaloseverbindung und arzneimittel mit der verbindung

Info

Publication number
ATE504592T1
ATE504592T1 AT07739277T AT07739277T ATE504592T1 AT E504592 T1 ATE504592 T1 AT E504592T1 AT 07739277 T AT07739277 T AT 07739277T AT 07739277 T AT07739277 T AT 07739277T AT E504592 T1 ATE504592 T1 AT E504592T1
Authority
AT
Austria
Prior art keywords
compound
trehalose
present
drugs containing
independently represent
Prior art date
Application number
AT07739277T
Other languages
English (en)
Inventor
Mugio Nishizawa
Hiroshi Imagawa
Hirofumi Yamamoto
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Application granted granted Critical
Publication of ATE504592T1 publication Critical patent/ATE504592T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04Disaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT07739277T 2006-03-27 2007-03-22 Trehaloseverbindung und arzneimittel mit der verbindung ATE504592T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006085245 2006-03-27
PCT/JP2007/055834 WO2007111214A1 (ja) 2006-03-27 2007-03-22 トレハロース化合物および該化合物を含有する医薬

Publications (1)

Publication Number Publication Date
ATE504592T1 true ATE504592T1 (de) 2011-04-15

Family

ID=38541134

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07739277T ATE504592T1 (de) 2006-03-27 2007-03-22 Trehaloseverbindung und arzneimittel mit der verbindung

Country Status (12)

Country Link
US (1) US8163713B2 (de)
EP (1) EP2000473B1 (de)
JP (1) JP5114627B2 (de)
KR (1) KR101412082B1 (de)
CN (1) CN101443344B (de)
AT (1) ATE504592T1 (de)
DE (1) DE602007013730D1 (de)
DK (1) DK2000473T3 (de)
ES (1) ES2362940T3 (de)
PT (1) PT2000473E (de)
TW (1) TWI382989B (de)
WO (1) WO2007111214A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100093993A1 (en) * 2007-01-31 2010-04-15 Otsuka Chemical Co., Ltd. Trehalose compound, process for production of the compound, and immuno-stimulative agent comprising the compound
JP5552056B2 (ja) * 2008-10-31 2014-07-16 株式会社糖鎖工学研究所 トレハロース化合物、その製造方法、及び該化合物を含有する医薬
WO2012122338A1 (en) * 2011-03-08 2012-09-13 Abbott Laboratories Process for the preparation of 1,2,4-oxadiazol-3-yl derivatives of carboxylic acid
WO2012147705A1 (ja) * 2011-04-24 2012-11-01 株式会社ネクスト21 トレハロースを含有する炎症性呼吸器疾患の治療剤
AU2014264228A1 (en) 2013-05-07 2015-11-12 Bio Blast Pharma Ltd. Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
US9084720B2 (en) 2013-05-07 2015-07-21 BioBlast Pharma Ltd. Compositions and methods for treating oculopharyngeal muscular dystrophy
US12064480B2 (en) 2018-04-13 2024-08-20 Glaxosmithkline Biologicals Sa Immunigenic alpha-branched trehalose-diesters
US12503482B2 (en) * 2019-01-08 2025-12-23 The Brigham And Women's Hospital, Inc. Compositions and methods for trehalose phospholipids
CN114929237A (zh) 2019-10-01 2022-08-19 西洛斯治疗有限公司 海藻糖制剂及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006514A (en) * 1986-03-20 1991-04-09 Sawai Pharmaceutical Co., Ltd. α,α-trehalose trimycolates and pharmaceutical compositions
US5049664A (en) 1988-08-26 1991-09-17 Sawai Pharmaceutical Co., Ltd. Trehalose derivatives
US6911526B2 (en) * 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
JPH11158073A (ja) 1997-09-26 1999-06-15 Takeda Chem Ind Ltd アデノシンa3拮抗剤
JPH11171727A (ja) * 1997-09-30 1999-06-29 Kanebo Ltd 身体洗浄剤組成物
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
US6686366B1 (en) * 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
KR100840727B1 (ko) 1999-12-02 2008-06-23 오에스아이 파마슈티컬스, 인코포레이티드 아데노신 a1, a2a 및 a3 수용체 특이 화합물 및 그의 사용방법
EP1469864A1 (de) * 2002-01-25 2004-10-27 Muscagen Limited Verbindungen verwendbar als adenosin-a3-rezeptor-agoniste
US7414036B2 (en) 2002-01-25 2008-08-19 Muscagen Limited Compounds useful as A3 adenosine receptor agonists
US20050010551A1 (en) * 2003-06-27 2005-01-13 Mcgeachie John S. Method of and system for determining connections between parties using private links

Also Published As

Publication number Publication date
ES2362940T3 (es) 2011-07-15
CN101443344B (zh) 2012-08-29
EP2000473A4 (de) 2009-03-11
US8163713B2 (en) 2012-04-24
DK2000473T3 (da) 2011-05-16
KR101412082B1 (ko) 2014-06-26
WO2007111214A1 (ja) 2007-10-04
PT2000473E (pt) 2011-07-01
JPWO2007111214A1 (ja) 2009-08-13
DE602007013730D1 (de) 2011-05-19
TWI382989B (zh) 2013-01-21
KR20080103603A (ko) 2008-11-27
JP5114627B2 (ja) 2013-01-09
TW200745153A (en) 2007-12-16
EP2000473A9 (de) 2009-03-25
EP2000473B1 (de) 2011-04-06
CN101443344A (zh) 2009-05-27
EP2000473A2 (de) 2008-12-10
US20100249057A1 (en) 2010-09-30

Similar Documents

Publication Publication Date Title
ATE504592T1 (de) Trehaloseverbindung und arzneimittel mit der verbindung
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
MY153045A (en) Oxopyrazine derivative and herbicide
WO2009072621A1 (ja) 置換ジヒドロアゾール化合物及び有害生物防除剤
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
TNSN07397A1 (en) Acetylene derivatives
TNSN08372A1 (en) Heterocyclic amides for use as pharmaceuticals
IL204621A (en) Amino Acid Derivatives - γ - In bicycles preparations containing them and their uses
TW200626559A (en) Anilino-pyrimidine analogs
TW200505874A (en) New compounds with therapeutic effect
MX2009007482A (es) Agentes antiparasitarios.
TW200745034A (en) New compounds
NO20071476L (no) Antidiuretiske midler.
MX2009003927A (es) Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes.
EP1719761A4 (de) Neue heterocyclische verbindung
ATE503746T1 (de) Neue imidazolidinderivate
MX2010008039A (es) Compuestos triciclicos que tienen actividad antagonista de factor de liberacion de corticotropina y composiciones farmaceuticas que contienen los mismos.
MX2009012471A (es) Compuestos 4´sustituidos que tienen afinidad al receptor 5-hidroxitriptamina 6.
MX2010001566A (es) Derivado de aminopirazolamida.
MY183326A (en) New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
NZ596653A (en) Total synthesis of salinosporamide a and analogs thereof
ATE500212T1 (de) Bisphenol monoester
EP1961734A4 (de) Aminverbindung und deren verwendung für medizinische zwecke
ATE519818T1 (de) Reversibel thermochrome zusammensetzung
SG154418A1 (en) Granular composition and production thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2000473

Country of ref document: EP